China Sunsine Chemical Holdings (QES) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
27 Oct, 2026Executive summary
FY2024 revenue rose 1% YoY to RMB3,515.5 mln, while record sales volume of 214,094 tonnes supported a 14% increase in net profit to RMB423.9 mln.
Profit before tax increased 29% to RMB585.1 mln despite ASP pressure and intense competition.
A strong cash position, zero debt and capacity expansion underpin the proposed FY2024 dividend increase.
Financial highlights
FY2024 gross profit rose 6% to RMB850.0 mln; gross margin expanded 1.3 pts to 24.2%.
FY2024 EPS was RMB44.34 cents, up 15% YoY; net profit increased from RMB372.4 mln to RMB423.9 mln.
2H2024 revenue was RMB1,766.4 mln, gross profit RMB416.4 mln, and net profit RMB235.1 mln, up 32% YoY.
Other income was RMB110.4 mln, including RMB55.6 mln interest income, RMB33.2 mln government compensation and RMB28.9 mln scrap sales; other gains of RMB32.3 mln were primarily FX gains.
Outlook and guidance
2025 outlook includes risks from high interest rates, geopolitical tensions, trade-war risks and domestic competition; stimulus and private-sector support may bolster confidence.
Management plans to maintain sales-production equilibrium and targets efficiency, waste reduction, cash-flow management and sustainable growth.
The 30,000-tonne-per-year insoluble sulphur Phase 2 is expected to begin trial runs in 1H2025; timing for the 40,000-tonne MBT Phase 2 is unannounced.
Latest events from China Sunsine Chemical Holdings
- Volume growth lifted gross profit and PBT, while higher taxes reduced net profit.QES
H1 2024 - Record volume could not offset lower ASP, cutting FY2023 net profit 42%.QES
H2 2023 - A 22% ASP decline outweighed 10% volume growth, cutting net profit 54%.QES
H1 2023 - Net profit rose 29% as record sales volume partly offset lower selling prices.QES
H1 2025 - Record sales volume and higher margins lifted revenue, while FX losses and working capital weighed on cash flow.QES
H1 2026 - Record volume growth could not offset lower ASP, cutting FY2025 revenue 7% and profit 4%.QES
H2 2025